Overview of Soft Tissue Sarcomas


Stage IV and Recurrent Soft Tissue Sarcoma: Limbs, Outer Trunk, Head, or Neck (March 17, 2016)

Overview Patients diagnosed with stage IV soft tissue sarcoma (STS) have a cancer of any size or grade that has spread to distant parts of the body such as the lungs. Sarcoma Centers & Second Opinions Because... Continue Reading

Stage II and III Soft Tissue Sarcoma: Limbs, Outer Trunk, Head or Neck (March 17, 2016)

Patients diagnosed with stage II or III soft tissue sarcoma (STS) are treated differently depending on the size of the primary tumor, the tumor grade, and whether or not the sarcoma has spread to the local... Continue Reading

Stage I Soft Tissue Sarcoma: Limbs, Outer Trunk, Head or Neck (March 17, 2016)

Overview Patients diagnosed with stage I soft tissue sarcoma (STS) have a low grade or unknown grade cancer that can be superficial or deep and does not involve any lymph nodes. Stage I STS is further... Continue Reading

Yondelis® Approved for Treatment of Soft Tissue Sarcoma (November 2, 2015)

The United States Food and Drug Administration (FDA) approved the chemotherapy agent, Yondelis® (trabectedin), for the treatment of liposarcoma and leiomyosarcoma—two types of soft-tissue sarcomas.1 The... Continue Reading

Yondelis® Bests Standard Therapy in Liposarcoma and Leiomyosarcoma (October 20, 2015)

The chemotherapy agent, Yondelis® (trabectedine), improves outcomes compared to the standard agent, DTIC (dacarbazine), in patients with advanced liposarcoma or leiomyosarcoma that has recurred or progressed... Continue Reading

Longer Overall Survival for Patients with Soft Tissue Sarcoma Treated with Halaven® (June 11, 2015)

Halaven® (eribulin) may extend overall survival in patients with previously treated, advanced soft tissue sarcoma (STS). These findings were presented at 2015 Annual Meeting of the American Society of... Continue Reading

YONDELIS® (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma (February 4, 2015)

The U.S. Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for YONDELIS® (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including... Continue Reading

Soft Tissue Sarcoma Screening and Prevention (March 22, 2007)

Overview Information about the prevention of cancer and the science of screening appropriate individuals at high risk of developing cancer is gaining interest. Physicians and individuals alike recognize... Continue Reading

Overview of Soft Tissue Sarcomas (March 22, 2007)

Overview Adult soft tissue sarcoma (STS) is a disease in which malignant (cancer) cells form in the soft tissues of the body. Soft tissues include the muscles, tendons, fat, blood and lymph vessels, nerves... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS